US5983956A
(en)
*
|
1994-10-03 |
1999-11-16 |
Astra Aktiebolag |
Formulation for inhalation
|
US5980949A
(en)
*
|
1994-10-03 |
1999-11-09 |
Astra Aktiebolag |
Formulation for inhalation
|
US6205999B1
(en)
|
1995-04-05 |
2001-03-27 |
Aerogen, Inc. |
Methods and apparatus for storing chemical compounds in a portable inhaler
|
US5758637A
(en)
|
1995-08-31 |
1998-06-02 |
Aerogen, Inc. |
Liquid dispensing apparatus and methods
|
US6427682B1
(en)
|
1995-04-05 |
2002-08-06 |
Aerogen, Inc. |
Methods and apparatus for aerosolizing a substance
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
GB9616047D0
(en)
|
1996-07-31 |
1996-09-11 |
Glaxo Group Ltd |
Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
|
US6458574B1
(en)
*
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
US6083725A
(en)
*
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
SE9700133D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
SE9700135D0
(sv)
*
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
IL134084A0
(en)
*
|
1997-07-18 |
2001-04-30 |
Infimed Inc |
Biodegradable macromers for the controlled release of biologically active substances
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6433040B1
(en)
*
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
ATE248583T1
(de)
*
|
1997-09-29 |
2003-09-15 |
Nektar Therapeutics |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
SK13632000A3
(sk)
|
1998-03-16 |
2001-03-12 |
Inhale Therapeutic Systems, Inc. |
Spôsob podávania aktívnej látky do pľúc ľudského pacienta a zariadenie na jeho vykonávanie
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
EP2258183A1
(de)
|
1998-12-22 |
2010-12-08 |
The University of North Carolina at Chapel Hill |
Verbindungen und Verwendungen zur Behandlung von Atemwegeserkrankungen sowie zur Verabreichung von Arzneistoffen für die Atemwege
|
US20020006901A1
(en)
*
|
1999-02-05 |
2002-01-17 |
Aldo T. Iacono |
Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
|
CA2369262A1
(en)
|
1999-04-13 |
2000-10-19 |
Sudha Nagarajan |
Pulmonary administration of dry powder formulations for treating infertility
|
EP1185248B1
(de)
*
|
1999-06-09 |
2012-05-02 |
Robert E. Sievers |
Überkritische fluidgestützte verneblung und blasen trochnen
|
US6606992B1
(en)
*
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
WO2001013891A2
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6235177B1
(en)
|
1999-09-09 |
2001-05-22 |
Aerogen, Inc. |
Method for the construction of an aperture plate for dispensing liquid droplets
|
ES2254164T3
(es)
*
|
1999-10-29 |
2006-06-16 |
Nektar Therapeutics |
Composiciones de polvo seco con dispersabilidad mejorada.
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
AU2729101A
(en)
|
1999-12-21 |
2001-07-03 |
Rxkinetix, Inc. |
Particulate drug-containing products and method of manufacture
|
US6761909B1
(en)
|
1999-12-21 |
2004-07-13 |
Rxkinetix, Inc. |
Particulate insulin-containing products and method of manufacture
|
DE60139110D1
(de)
|
2000-01-10 |
2009-08-13 |
Maxygen Holdings Ltd |
G-csf konjugate
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
US6948494B1
(en)
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
CA2382133C
(en)
*
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US6668827B2
(en)
*
|
2000-05-16 |
2003-12-30 |
Nektar Therapeutics |
Systems devices and methods for opening receptacles having a powder to be fluidized
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
US6514482B1
(en)
|
2000-09-19 |
2003-02-04 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
DE60232434D1
(de)
|
2001-02-27 |
2009-07-09 |
Maxygen Aps |
Neue interferon-beta-ähnliche moleküle
|
US7276580B2
(en)
*
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
US6546927B2
(en)
|
2001-03-13 |
2003-04-15 |
Aerogen, Inc. |
Methods and apparatus for controlling piezoelectric vibration
|
EG24184A
(en)
*
|
2001-06-15 |
2008-10-08 |
Otsuka Pharma Co Ltd |
Dry powder inhalation system for transpulmonary
|
US6939534B2
(en)
|
2001-08-13 |
2005-09-06 |
Genomed, Llc |
Method to treat pulmonary hypoplasia in the newborn
|
ITMI20012174A1
(it)
*
|
2001-10-18 |
2003-04-18 |
Univ Parma |
Polvere per somministrazione nasale di farmaci
|
CA2465675C
(en)
*
|
2001-11-20 |
2008-06-10 |
Advanced Inhalation Research, Inc. |
Improved particulate compositions for pulmonary delivery
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
ES2364636T3
(es)
|
2001-12-19 |
2011-09-08 |
Novartis Ag |
Administración pulmonar de aminoglucósidos.
|
US7677467B2
(en)
|
2002-01-07 |
2010-03-16 |
Novartis Pharma Ag |
Methods and devices for aerosolizing medicament
|
CA2472644C
(en)
|
2002-01-07 |
2013-11-05 |
Aerogen, Inc. |
Devices and methods for nebulizing fluids for inhalation
|
ES2603067T3
(es)
|
2002-01-15 |
2017-02-23 |
Novartis Ag |
Métodos y sistemas para hacer funcionar un generador de aerosol
|
WO2003075977A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
ES2609482T3
(es)
|
2002-03-20 |
2017-04-20 |
Civitas Therapeutics, Inc. |
Administración pulmonar de levodopa
|
WO2003088961A1
(en)
*
|
2002-04-19 |
2003-10-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
|
US20040071686A1
(en)
|
2002-04-25 |
2004-04-15 |
Treco Douglas A. |
Treatment of alpha-galactosidase A deficiency
|
EP1531795A4
(de)
|
2002-05-02 |
2011-02-23 |
Harvard College |
Formulierungen zur begrenzung der ausbreitung von lungeninfektionen
|
US20050220720A1
(en)
*
|
2002-05-02 |
2005-10-06 |
David Edwards |
Formulations limiting spread of pulmonary infections
|
EP1509259B1
(de)
|
2002-05-20 |
2016-04-20 |
Novartis AG |
Gerät zur bereitstellung eines aerosols für die medizinische behandlung und verfahren
|
US6930137B2
(en)
*
|
2002-05-31 |
2005-08-16 |
Fina Technology, Inc. |
Method of improving blown film processing performance and physical properties
|
US7185651B2
(en)
*
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
AU2003278565A1
(en)
*
|
2002-10-25 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
JP4571776B2
(ja)
*
|
2002-11-05 |
2010-10-27 |
Jx日鉱日石エネルギー株式会社 |
潤滑油組成物
|
WO2004054647A1
(en)
*
|
2002-12-13 |
2004-07-01 |
Otsuka Pharmaceutical Co., Ltd. |
Inhalation device for transpulmonary administration
|
ES2545619T3
(es)
|
2003-01-31 |
2015-09-14 |
The Mount Sinai School Of Medicine Of New York University |
Terapia de combinación para tratar trastornos de deficiencia de proteínas
|
NZ543365A
(en)
|
2003-04-18 |
2009-02-28 |
Biogen Idec Inc |
Polymer-conjugated glycosylated neublastin
|
US8616195B2
(en)
|
2003-07-18 |
2013-12-31 |
Novartis Ag |
Nebuliser for the production of aerosolized medication
|
PT1663235E
(pt)
|
2003-08-18 |
2013-10-29 |
Parion Sciences Inc |
Novos bloqueadores dos canais do sódio de pirazinoílguanidina protegida
|
WO2005079755A2
(en)
*
|
2004-02-12 |
2005-09-01 |
Nektar Therapeutics |
Interleukin-13 antagonist powders, spray-dried particles, and methods
|
US20050207983A1
(en)
*
|
2004-03-05 |
2005-09-22 |
Pulmatrix, Inc. |
Formulations decreasing particle exhalation
|
KR101204286B1
(ko)
|
2004-03-30 |
2012-11-26 |
엔에스진 에이/에스 |
성장 인자 NsG33의 치료학적 용도
|
US7946291B2
(en)
|
2004-04-20 |
2011-05-24 |
Novartis Ag |
Ventilation systems and methods employing aerosol generators
|
ES2618028T3
(es)
|
2004-07-19 |
2017-06-20 |
Biocon Limited |
Conjugados insulina-oligómero, formulaciones y usos de éstos.
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
KR101241551B1
(ko)
*
|
2004-08-19 |
2013-03-11 |
바이오겐 아이덱 엠에이 인코포레이티드 |
전환 성장 인자 베타 패밀리 단백질의 리폴딩
|
KR101215697B1
(ko)
*
|
2004-08-19 |
2012-12-28 |
바이오겐 아이덱 엠에이 인코포레이티드 |
뉴블라스틴 변형체
|
UA95446C2
(ru)
|
2005-05-04 |
2011-08-10 |
Іллюміджен Байосайєнсіз, Інк. |
Мутаци в генах oas1
|
EP2932982B1
(de)
|
2005-05-17 |
2018-10-03 |
Amicus Therapeutics, Inc. |
Verfahren zur Behandlung der Pompe-Krankheit mit 1-desoxynojirimycin und Derivaten
|
CA2608752A1
(en)
*
|
2005-05-18 |
2006-11-23 |
Pulmatrix Inc. |
Formulations for alteration of biophysical properties of mucosal lining
|
JP5064383B2
(ja)
|
2005-05-25 |
2012-10-31 |
エアロジェン,インコーポレイテッド |
振動システムと方法
|
US7474379B2
(en)
*
|
2005-06-28 |
2009-01-06 |
Asml Netherlands B.V. |
Lithographic apparatus and device manufacturing method
|
US20100119525A1
(en)
*
|
2005-08-01 |
2010-05-13 |
Mount Sinai Schoool Of Medicine Of New York University |
Method for extending longevity using npc1l1 antagonists
|
ATE465087T1
(de)
*
|
2005-11-21 |
2010-05-15 |
Mannkind Corp |
Gerät und verfahren zur pulverausgabe und messung
|
JP2009528295A
(ja)
|
2006-02-24 |
2009-08-06 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP1993590B1
(de)
*
|
2006-03-01 |
2013-12-25 |
Biogen Idec MA Inc. |
Zusammensetzungen und verfahren zur verabreichung von proteinen der gdnf-liganden-familie
|
TWI445544B
(zh)
*
|
2007-05-01 |
2014-07-21 |
Biogen Idec Inc |
增進血管形成之組合物及方法
|
WO2009020964A2
(en)
*
|
2007-08-08 |
2009-02-12 |
Biogen Idec Ma Inc. |
Anti-neublastin antibodies and uses thereof
|
CA2713413C
(en)
|
2008-02-26 |
2018-11-20 |
Parion Sciences, Inc. |
Poly aromatic sodium channel blockers
|
US9221561B2
(en)
|
2008-08-05 |
2015-12-29 |
Mannkind Corporation |
Powder dispenser modules and powder dispenser assemblies
|
US20110171312A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Modified therapeutic peptides, methods of their preparation and use
|
US20110166063A1
(en)
|
2008-09-19 |
2011-07-07 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
PT2389372E
(pt)
|
2009-01-23 |
2016-01-07 |
Rigel Pharmaceuticals Inc |
Composições e métodos para a inibição da via jak
|
CA2758271C
(en)
|
2009-04-09 |
2018-06-05 |
Robert Boyd |
Methods for preventing and/or treating lysosomal storage disorders
|
JP5908397B2
(ja)
|
2009-06-09 |
2016-04-26 |
デフィルス、インコーポレイテッドDefyrus, Inc. |
病原体感染を予防又は治療するためのインターフェロン投与
|
US8604057B2
(en)
|
2009-10-19 |
2013-12-10 |
Amicus Therapeutics, Inc. |
Compositions for preventing and/or treating lysosomal storage disorders
|
EP2490532B1
(de)
|
2009-10-19 |
2016-11-23 |
Amicus Therapeutics, Inc. |
Neue zusammensetzungen zur prävention und/oder behandlung von degenerativen erkrankungen des zentralnervensystems
|
US20130102591A1
(en)
|
2010-01-26 |
2013-04-25 |
Andrew Lurie Salzman |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
US20130115212A1
(en)
|
2010-06-14 |
2013-05-09 |
Lundbeck A/S |
Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors
|
EP2464346A1
(de)
|
2010-08-30 |
2012-06-20 |
Pulmatrix, Inc. |
Behandlung zystischer fibrose mit calciumlactat, leukin und natriumchlorid in einem einatembaren trockenpulver
|
CN105640925B
(zh)
|
2010-08-30 |
2019-08-16 |
普马特里克斯营业公司 |
干燥粉末配方及用于治疗肺部疾病的方法
|
KR101915241B1
(ko)
|
2010-09-29 |
2018-11-06 |
풀매트릭스 오퍼레이팅 컴퍼니, 인크 |
흡입용의 1가 금속 양이온 건조 분말
|
CA2812417C
(en)
|
2010-09-29 |
2019-10-22 |
Pulmatrix, Inc. |
Cationic dry powders
|
CA2754237A1
(en)
|
2011-05-27 |
2012-11-27 |
The Regents Of The University Of California |
Cyanoquinoline compounds having activity in correcting mutant-cftr processing and increasing ion transport and uses thereof
|
CN103687488B
(zh)
|
2011-06-27 |
2015-06-10 |
帕里昂科学公司 |
化学和代谢稳定的具有钠通道阻滞剂活性的二肽
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
CN109999013A
(zh)
|
2012-02-29 |
2019-07-12 |
普马特里克斯营业公司 |
可吸入干粉剂
|
BR112014023611B1
(pt)
*
|
2012-03-23 |
2021-08-31 |
Pharma73, S.A. |
Pó biocomposto, método de preparação de um pó biocomposto e utilização do referido pó biocomposto
|
WO2013142038A2
(en)
|
2012-03-23 |
2013-09-26 |
Oxigene, Inc. |
Compositions and methods for inhibition of cathepsins
|
AU2013240486B2
(en)
|
2012-03-27 |
2017-10-26 |
Amicus Therapeutics, Inc. |
Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
|
RU2015146871A
(ru)
|
2013-04-01 |
2017-05-10 |
Пулматрикс, Инк. |
Сухие порошки с тиотропием
|
EP3105235B1
(de)
|
2014-02-12 |
2019-11-06 |
Amicus Therapeutics, Inc. |
Zuckerderivate mit schwefelhaltigen gruppen und verfahren zur herstellung davon und verfahren zur verwendung davon zur behandlung von mps iiic
|
US9675627B2
(en)
|
2014-04-14 |
2017-06-13 |
Amicus Therapeutics, Inc. |
Dosing regimens for treating and/or preventing cerebral amyloidoses
|
MX2016015197A
(es)
|
2014-05-21 |
2017-06-29 |
Pharma73 S A |
Complejo de quitina-glucano, su preparacion y usos.
|
KR101746911B1
(ko)
|
2014-12-26 |
2017-06-28 |
주식회사 종근당 |
활성성분의 입도 및 활성성분을 포함하는 과립의 입도가 이중으로 조절된 약제학적 조성물
|
US10179128B2
(en)
|
2015-08-31 |
2019-01-15 |
Amicus Therapeutics, Inc. |
Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
|
NL2017294B1
(en)
|
2016-08-05 |
2018-02-14 |
Univ Erasmus Med Ct Rotterdam |
Natural cryptic exon removal by pairs of antisense oligonucleotides.
|
BR112019013503A2
(pt)
|
2016-12-31 |
2020-01-07 |
Bioxcel Therapeutics, Inc. |
Uso de dexmedetomidina sublingual para o tratamento da agitação
|
KR20190134807A
(ko)
|
2017-04-25 |
2019-12-04 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
중추 신경계의 퇴행성 질환 및/또는 리소솜 저장병을 예방 및/또는 치료하기 위한 신규한 조성물
|
AU2019295699A1
(en)
|
2018-06-27 |
2021-01-28 |
Arx, Llc |
Film formulations containing dexmedetomidine and methods of producing them
|
US20220000880A1
(en)
|
2018-11-01 |
2022-01-06 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
US11160791B2
(en)
|
2018-11-01 |
2021-11-02 |
Medefil, Inc. |
Dexmedetomidine injection premix formulation in ready to use (RTU) bags
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
MX2022000709A
(es)
|
2019-07-19 |
2022-05-19 |
Bioxcel Therapeutics Inc |
Regimenes de tratamiento con dexmedetomidina no sedante.
|
WO2021026451A1
(en)
|
2019-08-08 |
2021-02-11 |
Rigel Pharmaceuticals, Inc. |
Compounds and method for treating cytokine release syndrome
|
MX2022001890A
(es)
|
2019-08-14 |
2022-04-26 |
Rigel Pharmaceuticals Inc |
Metodo para bloquear o mejorar el sindrome de liberacion de citocinas.
|
US11365248B2
(en)
|
2020-06-29 |
2022-06-21 |
Anovent Pharmaceutical (U.S.), Llc |
Formulation of tocilizumab and method for treating COVID-19 by inhalation
|
US20230303555A1
(en)
|
2022-03-23 |
2023-09-28 |
Rigel Pharmaceuticals, Inc. |
Pyrimid-2-yl-pyrazole compounds as irak inhibitors
|